Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NEURONETICS, INC.

(STIM)
  Rapport
Temps Différé Nasdaq  -  22:00 02/12/2022
6.190 USD   -0.16%
14/11Neuronetics, Inc. Annonce de nouvelles avancées du système de thérapie avancée NeuroStar
CI
08/11Transcript : Neuronetics, Inc., Q3 2022 Earnings Call, Nov 08, 2022
CI
08/11Neuronetics, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur NEURONETICS, INC.
21/11Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference
14/11Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations
14/11Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations
14/11Neuronetics, Inc. Announces New Advancements of NeuroStar Advanced Therapy System
10/11Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/11NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
08/11Neuronetics : STIM Corporate Presentation November 2022
08/11Neuronetics : Supplemental Financial and Operating Information - November 2022
08/11Neuronetics : Q3 Earnings Snapshot
08/11Neuronetics, Inc. : Regulation FD Disclosure (form 8-K)
08/11Earnings Flash (STIM) NEURONETICS Posts Q3 Revenue $16.5M, vs. Street Est of $15M
08/11Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
08/11Neuronetics Reports Third Quarter 2022 Financial and Operating Results
08/11Neuronetics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 20..
31/10Neuronetics Announced as Winner by 2022 Merit Awards for Technology
31/10Neuronetics Announced as Winner by 2022 Merit Awards for Technology
25/10Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to ..
25/10Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to ..
25/10Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Confe..
27/09Neuronetics Launches Innovations To NeuroStar Advanced Therapy's Proprietary TrakStar P..
26/09Neuronetics Launches Innovations To NeuroStar® Advanced Therapy's Proprietary TrakStar®..
26/09Neuronetics Launches Innovations To NeuroStar® Advanced Therapy's Proprietary TrakStar®..
26/09Neuronetics, Inc. Launches Innovations to Neurostar Advanced Therapy’s Proprietary..
13/09Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting ..
13/09Neuronetics, Inc. Announces Grand Opening of Neurostar University with Ribbon-Cutting C..
29/08Neuronetics Receives FDA Clearance for D-Tect Accessory Product
29/08Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Adv..
29/08Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Adva..
26/08Bruce J. Shook Notifies the Board of Directors of Neuronetics, Inc. to Resign from the ..
08/08Neuronetics Files $125 Million Mixed Shelf
05/08Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/08NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
02/08Neuronetics : Q2 Earnings Snapshot
02/08Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
02/08Neuronetics : Supplemental Financial and Operating Information
02/08Neuronetics : STIM Corporate Presentation August 2022
02/08Neuronetics Reports Second Quarter 2022 Financial and Operating Results
02/08Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
02/08Neuronetics : Reports Second Quarter 2022 Financial and Operating Results - Form 8-K
02/08Neuronetics, Inc. : Regulation FD Disclosure (form 8-K)
02/08Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
28/07Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
25/07Neuronetics Agrees to Supply Transcranial Magnetic Stimulation Systems to Alleviant Hea..
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
19/07Insider Sell: Neuronetics
19/07Neuronetics Gets FDA Nod for Magnetic Stimulation System to Treat Anxious Depression; S..
19/07Top Midday Gainers
19/07Neuronetics Shares Rise 14% After FDA Clearance for Anxiety Treatment
19/07Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conf..
19/07Top Premarket Gainers
19/07Neuronetics Says FDA Clears Magnetic Stimulation System to Treat Major Depressive Disor..
19/07Neuronetics Gets FDA Clearance for NeuroStar to Treat Anxious Depression
19/07NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of A..
19/07NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of A..
19/07Neurostics Inc. Receives U.S. Food and Drug Administration Clearance for Treatment of A..
18/07Neuronetics, Inc. : Termination of a Material Definitive Agreement (form 8-K)
13/07Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
13/07Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
11/07Neuronetics Says Two Medicare Administrators Expanding Access to Transcranial Magnetic ..
11/07Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroS..
11/07Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroS..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E I..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E V..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Dy..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E G..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Microca..
21/06Cannell Capital LLC Communicates with Neuronetics Inc
27/05Neuronetics, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
25/05Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
17/05New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Ther..
17/05New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Ther..
12/05NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
12/05Neuronetics : Q1 Earnings Snapshot
12/05Earnings Flash (STIM) NEURONETICS Posts Q1 Revenue $14.2M, vs. Street Est of $13.5M
12/05Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
12/05Neuronetics, Inc. : Regulation FD Disclosure (form 8-K)
12/05Neuronetics Reports First Quarter 2022 Financial and Operating Results
12/05Neuronetics, Inc. Provides Earning Guidance for the Second Quarter and Full Year of 202..
12/05North American Morning Briefing: Stocks Seen -3-
11/05Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
11/05Neuronetics, Inc. and Transformations Care Network Announce Extended Commercial Partner..
11/05Neuronetics Sues BrainsWay for Misleading Psychiatrists, Patients On NeuroStar Efficacy
11/05Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
11/05Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
11/05Neuronetics Files Federal Lawsuit Against Brainsway for Misleading Psychiatrists and Pa..
10/05Neuronetics Shares Reverse Course, Hit 52-Week Low
Prochain événement sur NEURONETICS, INC.